ANDREA JOHNSON: Open Payments
NPI 1700939220 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 102 payments from 23 companies in 2025. Trend: 2023 $241 · 2024 $1,134 · 2025 $1,655
Food & beverage: $1,655
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $354 |
| AstraZeneca Pharmaceuticals LP | 16 | $261 |
| Novo Nordisk Inc | 16 | $260 |
| PFIZER INC. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 5 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Lilly USA, LLC | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Exact Sciences Corporation | 3 | $55 |
Products named: VRAYLAR, Ozempic, FARXIGA, Wegovy, REXULTI, AIRSUPRA, GEMTESA, CAPLYTA.
Industry payments across NC — which companies pay providers there.
